9 months ago
CAR-T Immune Cell Therapy for Lymphoma: A Comprehensive Guide Lymphoma, a malignant tumor originating from the lymphatic system, has seen a rising incidence rate in recent years. As a cutting-edge ...
9 months ago
**Nature Medicine | New Breakthrough in China’s CAR-T Therapy: Significant Progress in Allogeneic CD5 CAR-T Treatment for Relapsed T-ALL** T-ALL #CAR-TTherapy #TALL #ALL #Leukemia #RelapsedLe...
9 months ago
Tecartus and Non Hodgkin’s Lymphoma Non-Hodgkin’s lymphoma (NHL) is a diverse group of blood cancers that originate from lymphocytes, a type of white blood cell. Mantle cell lymphoma (M...
9 months ago
### China’s BCMA CAR-T Therapy Offers Last Hope for Relapsed Multiple Myeloma Patients CAR-T Therapy #MultipleMyeloma #CAR_TTherapy #BCMACART #CART Multiple myeloma remains a difficult-to-...
9 months ago
**Why Does China Have a Unique Advantage in the Field of CAR-T Therapy?** CAR-T #CAR_Therapy #CancerTreatment #MedicalInnovation #ChinaMedical In recent years, China has made rapid advancements in...
9 months ago
Yescarta Treatment: A Comprehensive Overview Yescarta, also known as axicabtagene ciloleucel, is a revolutionary immunotherapy treatment that has shown significant promise in the field of oncology,...
9 months ago
Blood Cancer – Diagnosis and Treatment Tips #leukemia #multiplemyeloma #lymphoma Blood Cancer Blood cancer, encompassing types such as leukemia, lymphoma, and multiple myeloma, represen...
9 months ago
🌟 **Nature Headline!** China’s CAR-T Therapy Breakthrough Leads the World—A New Hope for Autoimmune Disease Treatment Autoimmune #CAR_Therapy #CRISPR #AutoimmuneDisease #Immunotherapy #Nature #Auto...
9 months ago
**China’s CAR-T Therapy Brings Complete Remission for Primary Refractory Multiple Myeloma Patient** Multiple Myeloma #MultipleMyeloma #CARTtherapy #BloodCancer #CompleteRemission #CART M...
9 months ago
The significance of the 11 CD19 and BCMA CAR-T therapies currently approvedin China and the U.S. forpatients with hematologic malignancies. 目前中美上市的11款CD19和BCMA CAR-T对血液瘤患者的意义 E...
9 months ago
**BCMA CAR-T Therapy Paves New Path for Treating High-Risk Multiple Myeloma** Multiple Myeloma Multiple Myeloma (MM) is a malignant tumor originating from plasma cells, known for its complex biolog...
9 months ago
Yescarta therapy: A Groundbreaking CAR-T Treatment for Aggressive Lymphomas CAR-T cell therapy is a revolutionary form of cancer treatment that harnesses the power of the patient’s own immune...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
